NetworkNewsBreaks Archive - Page 2042 of 2178

FridaySep 08, 2017 12:01 pm

NetworkNewsBreaks – Novocure (NASDAQ: NVCR) Receives ‘Buy’ Rating from Mizuho Securities

Mizuho Securities USA LLC has initiated coverage with a ‘Buy’ rating and price target of $25 on shares of Novocure’s (NASDAQ: NVCR) stock. Mizuho analysts noted the company’s novel treatment for cancer, Optune, has demonstrated a strong five-year overall survival benefit on cancer patients with glioblastoma (GBM), and the analyst believes it will continue to do well in the medical community. Therefore, the analyst believes Novocure will hit estimated full-year revenue of $165 million in 2017, which would represent a 95% year-over-year increase. For more information, visit www.Novocure.com About Novocure Novocure is an oncology company developing a profoundly different cancer…

FridaySep 08, 2017 11:59 am

NetworkNewsBreaks – Mizuho Securities Initiates Coverage with ‘Buy’ Rating on Aerie Pharmaceuticals, Inc. (NASDAQ: AERI)

Mizuho Securities USA LLC has initiated coverage and issued a ‘Buy’ rating and price target of $70 on shares of Aerie Pharmaceuticals, Inc.’s (NASDAQ: AERI) stock. The analyst cites the company’s two glaucoma drugs as being well-positioned for FDA approvals, with Rhopressa anticipated for approval in the first half of 2018 and Roclatan expected to be approved in the first half of 2019. Given the strong efficacy and safety profiles of both drug candidates, the analyst believes it is likely they will both be approved. Additionally, the analyst believes that by the year 2025 the company could reach $239 million…

FridaySep 08, 2017 9:14 am

NetworkNewsBreaks – Leafbuyer Technologies (LBUY) Enters Deal with Leading Dispensary Chain

Leafbuyer Technologies, Inc. (OTC: LBUY), a leading cannabis technology platform known as the premier cannabis deals network, is adding Rocky Road Remedies to its client base. Leafbuyer will provide a suite of services to Rocky Road Remedies, a leading cannabis dispensary chain with six locations in Colorado. Leafbuyer drives business to dispensaries and product clients through its online platform, Leafbuyer.com In the news release, Leafbuyer vice president of business development and co-founder Mark Breen said, “We are committed to driving business to our customer base as well as providing the best deals for the consumer in the cannabis industry.” To…

ThursdaySep 07, 2017 1:09 pm

NetworkNewsBreaks – Organigram (TSX.V: OGI) (OTCQB: OGRMF) Enters into MOU for Microwave Assisted Extraction Technique Development

Organigram Holdings Inc. (TSX.V: OGI) (OTCQB: OGRMF) will jointly develop an industry leading method of microwave extraction of cannabinoid extracts from marijuana plants with the New Brunswick Innovation Research Chair in Medical Technologies (NBIRC), an initiative of the New Brunswick Innovation Fund (NBIF), it was announced Wednesday. A memorandum of understanding between Organigram Holdings Inc. and NBIRC details the project which will focus on developing a more efficient manner of extracting cannabinoids for use in extracts and edibles. The project will be led by Dr. J. R. Jocelyn Paré, holder of the NBIRC, the inventor of various Microwave-Assisted Processes forming…

ThursdaySep 07, 2017 1:04 pm

NetworkNewsBreaks – Cannabics Pharmaceuticals (CNBX) Files Patent Application for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) has filed an extensive provisional patent application with the U.S. Patent & Trademark Office on a new “Method for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs.” The method, developed by Cannabics Pharmaceuticals, expands the company’s proprietary technology of personalization of cannabinoid medicine. The current invention pertains to a combined method and system for assessing the sensitivity of a variety of cannabinoid-based treatment modalities on patient-derived primary tumor biopsies as well as blood circulating tumor cells (CTC). In the news release, Dr. Moran Grinberg, Cannabics Pharmaceuticals Vice President of Research and Development,…

ThursdaySep 07, 2017 12:53 pm

NetworkNewsBreaks – EVIO, Inc.’s (SGBYD) EVIO Labs Division Enters Cannabis Testing License Agreement in Colorado

EVIO, Inc. (OTCQB: SGBYD) this morning said that its cannabis testing division, EVIO Labs, has entered into an agreement with Phytatech CO, LLC to license its brand and cannabis technology in Colorado. Per the agreement, Phytatech will now operate under the EVIO Labs brand. "As we continue our mission to become the industry’s largest cannabis testing company, with operations in California, Oregon, Massachusetts, and Florida, EVIO is honored to now offer its accredited testing services to Colorado,” EVIO chief executive officer William Waldrop stated in the news release. To view the full press release, visit: http://nnw.fm/LDp24 About EVIO EVIO, Inc.…

ThursdaySep 07, 2017 12:36 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 7, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DRYS 11.57% – News: Takes delivery of the second newbuilding Very Large Gas Carrier TCON 10.45% – News: Completes enrollment in the phase 2b TRAXAR study HDYN 9.83% – News: Completes a private placement offering FRTA 8.60% – News: Appoints new executive VP and chief financial officer MBVX 8.56% – News: Presenting at the 19th Annual Rodman & Renshaw Global Investment Conference on September 12 NXTD 4.84% – News: FitPay collaborates with Bank of…

ThursdaySep 07, 2017 12:06 pm

NetworkNewsBreaks – Cleantech Solutions International, Inc. (NASDAQ: CLNT) Enters into Agreement with ECoin Development to Create a Cryptocurrency System

Shares of Cleantech Solutions International (NASDAQ: CLNT) are up 11% this morning after the company said it has entered into exclusive discussions with ECoin Development Limited regarding the development and operation of a cryptocurrency system to support the development of a sharing economy ecosystem based on blockchain solutions. Cleantech’s board of directors intends to form a special committee consisting of independent directors to assess and negotiate the potential acquisition and business cooperation transactions with ECoin on behalf of the company. "By implementing blockchain technology into the sharing economy, there will no longer be a need for a central authority. The…

ThursdaySep 07, 2017 12:04 pm

NetworkNewsBreaks – Neuralstem, Inc. (NASDAQ: CUR) Receives Two New US Patents

Neuralstem (NASDAQ: CUR) this morning said that is has received two additional patents from the United States Patent and Trademark Office (USPTO). The two newly-awarded patents broadly protect methods for using neural stem cells to treat neurodegenerative disorders, a crucial factor of the biopharmaceutical company’s platform. One of the new patents covers methods of treating neurodegenerative disorders through transplantation of neural stem cells. The other patent covers neural stem cells engineered to express IGF-1, a neurotrophic molecule with broad therapeutic potential in the treatment of neurodegenerative disorders. "Neuralstem now owns or licenses over 20 U.S. and 120 foreign issued and pending patents,…

ThursdaySep 07, 2017 12:01 pm

NetworkNewsBreaks – SeeThruEquity Initiates Coverage on LongFin Corp. (NASDAQ: LFIN)

SeeThruEquity has initiated coverage and set a price target of $8.42 on shares of LongFin Corp.’s (Nasdaq pending, "LFIN") stock. LongFin is a non-banking Fintech company providing structured commodity trade finance (shadow banking) solutions and is currently pending listing on the Nasdaq Capital Market. Among other highlights, the analyst noted the company’s goal of connecting 70 FX and spot exchanges and more than 300 banks across the globe via its electronic market making (EMM) trading platform. The shadow banking industry was estimated at $34 trillion in 2015 and is expected to grow further as the global trade financing gap continues…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks